The Annals the journal of Pharmacy Technology
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 36, No. 12, pp. 1929-1937. DOI 10.1345/aph.1C151
© 2002 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jung, R
Right arrow Articles by MacLaren, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jung, R
Right arrow Articles by MacLaren, R


Research Articles

Proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients

R Jung and R MacLaren

OBJECTIVE: To evaluate the use of proton-pump inhibitors (PPIs) for stress ulcer prophylaxis in critically ill adults. DATA SOURCES: Computerized biomedical literature search of MEDLINE (1966-June 2002) was conducted using the MeSH headings proton-pump inhibitor, ulcer, critical care, and acid. References of selected articles were reviewed. A manual search of critical care, surgery, trauma, gastrointestinal, and pharmacy journals was conducted to identify relevant abstracts. DATA SYNTHESIS: Traditional medications used for stress ulcer prophylaxis include antacids, histamine(2) receptor antagonists (H(2)RAs), and sucralfate. Few studies have evaluated PPIs for stress ulcer prophylaxis. The majority of studies have demonstrated that enteral or intravenous administration of PPIs to critically ill patients elevates intragastric pH and consistently maintains pH > or =4.0. PPIs are safe and seem to be as efficacious as H(2)RAs or sucralfate for prevention of bleeding from stress-related mucosal damage (SRMD) and they may provide cost minimization. The small patient populations limit the results of comparative studies. CONCLUSIONS: Available data indicate that PPIs are safe and efficacious for elevating intragastric pH in critically ill patients. PPIs should be used only as an alternative to H(2)RAs or sucralfate since the superiority of PPIs over these agents for preventing SRMD-associated gastrointestinal bleeding has not been established. Additional comparative studies with adequate patient numbers and pharmacoeconomic analyses are needed before PPIs are considered the agents of choice for stress ulcer prophylaxis.


This article has been cited by other articles:


Home page
NeurologyHome page
M. J. O'Donnell, M. K. Kapral, J. Fang, G. Saposnik, J. W. Eikelboom, W. Oczkowski, J. Silva, L. Gould, C. D'Uva, F. L. Silver, et al.
Gastrointestinal bleeding after acute ischemic stroke
Neurology, August 26, 2008; 71(9): 650 - 655.
[Abstract] [Full Text] [PDF]


Home page
Crit Care NurseHome page
M. J. Spirt and S. Stanley
Update on Stress Ulcer Prophylaxis in Critically Ill Patients
Crit. Care Nurse, February 1, 2006; 26(1): 18 - 28.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
J. W Devlin, L. S Welage, and K. M Olsen
Proton Pump Inhibitor Formulary Considerations in the Acutely Ill Part 2: Clinical Efficacy, Safety, and Economics
Ann. Pharmacother., November 1, 2005; 39(11): 1844 - 1851.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2002 by Harvey Whitney Books Company.